skip to the main content


Screening the pharmacokinestics of infliximab-treated patients with reliable test result

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment in patients with IBD (Inflammatory Bowel Disease) and RA (Rheumatoid Arthritis). AFIAS Infliximab test can measure Infliximab level with a small amount of human serum, plasma, and whole blood in 10 minutes. It provides information regarding the patients’ response to the treatment of infliximab. The test result can help with clinical decision making.


Available Instruments

About Using Reagent

  • Sample Types

    plasma, serum, and whole blood
  • Reaction Time

    10mins (AFIAS)
  • Detection Range

    AFIAS 0.2~50 μg/mL
  • Intended Use

    Fast and reliable measurement for the level of infliximab in blood

In Your Medical Field

AFIAS Infliximab is a therapeutic drug monitoring (TDM) to measure Infliximab level in patients’ blood using whole blood, serum, and plasma. With the TDM result, clinicians can check the patient’s response to the drug. It allows patients to get a customized treatment.